
CRISPR Therapeutics AG CRSP.BN:
CRISPR THERAPEUTICS AND SIRIUS THERAPEUTICS ANNOUNCE MULTI-TARGET COLLABORATION TO DEVELOP NOVEL SIRNA THERAPIES
CRISPR THERAPEUTICS AG: WILL MAKE AN UPFRONT PAYMENT OF $25 MILLION IN CASH AND $70 MILLION IN EQUITY TO SIRIUS THERAPEUTICS
CRISPR THERAPEUTICS AG: ALSO HAS RIGHTS TO EXCLUSIVELY LICENSE UP TO TWO ADDITIONAL SIRNA PROGRAMS
CRISPR THERAPEUTICS AG - SRSD107 SHOWS >93% FXI REDUCTION IN PHASE 1 TRIAL